Partner Therapeutics, Inc. was awarded a $748,912 definite contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to conduct research and development of diagnostic tests for patients with sepsis and immunoparalysis. The contract was awarded under Special Instructions 019 of the agency's Easy Broad Agency Announcement BAA-20-100-SOL-0002 vehicle. Special Instructions 019 sought host-directed therapeutic candidates to aid long-term outcomes from lung injury through Area of Interest 12 by facilitating safety review through Phase I clinical trials and sharing of data and commercialization plans. Work will be performed by Partner Therapeutics in Lexington, Massachusetts over a period of performance from September 2021 through July 2023. No subcontractors or set aside designations were identified.
Generated 12/29/23, 4:19 PM